Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Elabscience® has announced a major upgrade to its antibody product portfolio with the adoption of recombinant rabbit monoclonal antibody technology. This innovation significantly enhances antibody specificity, reproducibility, and stability, meeting the growing global demand for high-performance research reagents. - November 19, 2025
Press Releases 1 - 1 of 1